Showing results (3591-3600 of 9,339) with videos related to

Sort By:
Pageof 934
Cancer Medicine|July 5, 2024
Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective studyHaifeng Zheng, Zimian Luo, Yafei Yi, et al.
Cancer Medicine|July 5, 2024
Safety and efficacy of fruquintinib-based therapy in patients with advanced or metastatic sarcomaChenliang Zhou, Guowei Qian, Yonggang Wang, et al.
Cancer Medicine|July 5, 2024
Perspective of obstetric care-providers on being involved in cervical cancer screening during antenatal care in the NetherlandsNick M A van der Hoeven, A J C van den Brule, H J van Beekhuizen, et al.
Cancer Medicine|July 4, 2024
Disease-specific health-related quality of life trajectories up to 15 years after curative treatment for esophageal cancer-a prospective cohort studyZhao Cheng, Asif Johar, Jesper Lagergren, et al.
Cancer Medicine|June 12, 2024
A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resectionQu Xie, Zeyin Zhao, Yanzhen Yang, et al.
Cancer Medicine|June 11, 2024
Identification of PSMD11 as a novel cuproptosis- and immune-related prognostic biomarker promoting lung adenocarcinoma progressionQiumin Huang, Ran Tian, Jinxi Yu, et al.
Cancer Medicine|June 11, 2024
Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016)Peng Xu, Wen Luo, Jingjing Hu, et al.
Cancer Medicine|June 12, 2024
Cervical cancer-specific long non-coding RNA landscape reveals the favorable prognosis predictive performance of an ion-channel-related signature modelBochang Wang, Wei Wang, Wenhao Zhou, et al.
Cancer Medicine|June 12, 2024
miR-34a promotes the immunosuppressive function of multiple myeloma-associated macrophages by dampening the TLR-9 signalingRui Zhang, Disi Zhang, Yilan Luo, et al.
Cancer Medicine|June 12, 2024
Prevalence and prognosis of hypoxia-inducible factor-2α (HIF-2α) pathway gene mutations across advanced solid tumorsWenjun Zhong, Jiemin Ma, Cai Chen, et al.
Pageof 934